The TGFβ Induced MicroRNAome of the Trabecular Meshwork.

Area of Science:

• Ophthalmology
• Molecular Biology
• Genetics

Background:

• Primary open-angle glaucoma (POAG) is a progressive optic neuropathy linked to elevated intraocular pressure (IOP).
• Current treatments for POAG primarily target aqueous humor dynamics to reduce IOP.
• New therapeutic strategies are needed due to limited patient response and side effects of existing medications.

Purpose of the Study:

• To investigate the impact of transforming growth factor beta (TGFβ) on microRNA (miRNA) expression in human trabecular meshwork (TM) cells.
• To understand the molecular mechanisms by which TGFβ contributes to POAG pathogenesis.
• To explore the potential of miRNAs as novel therapeutic targets for glaucoma.

Main Methods:

• Cultured human primary trabecular meshwork cells were treated with TGF-β1 and TGF-β2.
• MicroRNA (miRNA) expression profiling was performed on treated cells.
• Analysis included both miRNA-centric and pathway-centric views of gene regulation.

Main Results:

• TGF-β1 and TGF-β2 significantly altered miRNA expression profiles in human TM cells.
• Specific miRNAs were identified as responsive to TGFβ treatment.
• The study elucidated TGFβ-driven changes in cellular pathways relevant to glaucoma.

Conclusions:

• TGFβ plays a crucial role in regulating miRNA expression within the trabecular meshwork.
• Understanding these TGFβ-responsive miRNAs provides insights into POAG pathogenesis.
• miRNAs represent a promising avenue for developing innovative glaucoma therapies targeting the trabecular meshwork.